Effectiveness of casirivimab-imdevimab and sotrovimab during a SARS-CoV-2 Delta variant surge: a cohort study and randomized comparative effectiveness trial

…, D Ricketts, JN Kennedy, CJ Pidro… - JAMA Network …, 2022 - jamanetwork.com
Importance The effectiveness of monoclonal antibodies (mAbs), casirivimab-imdevimab and
sotrovimab, is unknown in patients with mild to moderate COVID-19 caused by the SARS-…

Effectiveness of casirivimab and imdevimab, and sotrovimab during Delta variant surge: a prospective cohort study and comparative effectiveness randomized trial

…, SK Montgomery, D Ricketts, JN Kennedy, CJ Pidro… - MedRxiv, 2021 - medrxiv.org
IMPORTANCE The effectiveness of monoclonal antibodies (mAbs), casirivimab and imdevimab,
and sotrovimab, for patients with mild to moderate COVID-19 from the Delta variant is …

The comparative effectiveness of COVID-19 monoclonal antibodies: a learning health system randomized clinical trial

…, D Ricketts, JN Kennedy, CJ Pidro… - Contemporary Clinical …, 2022 - Elsevier
Background Monoclonal antibodies (mAb) that neutralize SARS-CoV-2 decrease hospitalization
and death compared to placebo in patients with mild to moderate COVID-19; however, …

A learning health system randomized trial of monoclonal antibodies for COVID-19

…, SK Montgomery, D Ricketts, JN Kennedy, CJ Pidro… - medRxiv, 2021 - medrxiv.org
Background Neutralizing monoclonal antibodies (mAb) targeting SARS-CoV-2 decrease
hospitalization and death in patients with mild to moderate Covid-19. Yet, their clinical use is …

A Learning Health System Randomized Trial of Monoclonal Antibodies for Covid-19 (preprint)

…, SK Montgomery, DR MT, JN Kennedy, CJ Pidro… - 2021 - pesquisa.bvsalud.org
… Erin K McCreary PharmD; J Ryan Bariola MD; Tami Minnier MS; Richard J Wadas MD;
Judith A Shovel BSN; Debbie L Albin BS; Oscar C Marroquin MD; Kevin E Kip PhD; Kevin …

[HTML][HTML] A randomized trial of a family-support intervention in intensive care units

…, AM Shields, P Buddadhumaruk, C Pidro… - … England Journal of …, 2018 - Mass Medical Soc
Background Surrogate decision makers for incapacitated, critically ill patients often struggle
with decisions related to goals of care. Such decisions cause psychological distress in …

Protocol for a randomised trial of an interprofessional team-delivered intervention to support surrogate decision-makers in ICUs

…, F Pike, H Chen, E Brown, V Kozar, C Pidro… - BMJ open, 2020 - bmjopen.bmj.com
Introduction Although shortcomings in clinician–family communication and decision making
for incapacitated, critically ill patients are common, there are few rigorously tested …

Risk factors for functional decline and impaired quality of life after pediatric respiratory failure

RS Watson, LA Asaro, L Hutchins… - American journal of …, 2019 - atsjournals.org
Rationale: Poor outcomes of adults surviving critical illness are well documented, but data
in children are limited. Objectives: To identify factors associated with worse postdischarge …

[HTML][HTML] The salivary microbiota of patients with acute lower respiratory tract infection–A multicenter cohort study

MB Rogers, A Harner, M Buhay, B Firek, B Methé… - Plos one, 2024 - journals.plos.org
The human microbiome contributes to health and disease, but the oral microbiota is
understudied relative to the gut microbiota. The salivary microbiota is easily accessible, …

Long-term outcomes after protocolized sedation versus usual care in ventilated pediatric patients

RS Watson, LA Asaro, JH Hertzog… - American journal of …, 2018 - atsjournals.org
Rationale: Whether a nurse-implemented goal-directed sedation protocol resulting in more
awake yet calm intubated children affects postdischarge functional status, health-related …